Mr. Damian Kettlewell reports

BLISSCO APPOINTS FORMER HIGH-RANKING HEALTH CANADA EXECUTIVE TO BOARD OF DIRECTORS

Blissco Cannabis Corp. has appointed Meena Ballantyne to its board of directors.

Ms. Ballantyne has had a successful career in the federal public service of Canada where she held numerous senior positions such as deputy minister, status of women Canada, and assistant deputy minister. As the assistant deputy minister of health products and food branch at Health Canada she led the regulatory branch dealing with prescription drugs, biologics, medical devices and natural health products. She also served as assistant secretary for social development at the Privy Council of Canada where she provided advice to the Prime Minister and clerk of the privy council on issues relating to health, immigration and criminal justice reforms. Ms. Ballantyne has served on a number of boards and holds a director designation in corporate governance from the Institute of Corporate Directors.

"We are delighted to invite Ms. Ballantyne to join Blissco's board of directors. Her experience at some of the highest levels of Health Canada make her a fabulous candidate for our health and wellness-focused company," said Damian Kettlewell, chief executive officer and founder of Blissco Cannabis. "Meena enhances the diversity of our board, is well versed with board governance and we look forward to her guidance as we navigate this next exciting phase of growth with Blissco."

"I have been assessing board opportunities in the cannabis space and Blissco stood out to me as a team that is truly founded on the ethos of promoting wellness and improving the world at large," said Ms. Ballantyne. "I look forward to being a part of the company's growth during such a dynamic time in this emerging industry."

The company wishes to announce that it has retained Ariel Jack Lewinski to provide business development and investor relations services for a period of three months in exchange for $10,000 per month and granted 30,000 options at a price of 31.5 cents per share, exercisable for a period of three years.

Furthermore, the company announces that it has granted to its officers, directors and employees an aggregate of 1.1 million stock options, exercisable for a period of three years, at a price of 31.5 cents per share. Of the options, 300,000 options are exercisable for a period of three years and the remaining 800,000 options are exercisable for a period of 10 years.

About Blissco Cannabis Corp.

Blissco Cannabis is a wellness-focused, licensed producer and future distributor of ultrapremium cannabis. The company sits at the heart of an international ecosystem and is focused on the success of its domestic and global partnerships. Blissco leverages the latest technology and is continuously developing its network of top-tier industry experts to drive the success of its brand and channels, moving premium Canadian cannabis to local and international markets.

We seek Safe Harbor.